-
Assessing Disease Progression in MSA: Development of a Bayesian Progression Model
-
Assessing Genome-wide Genetic Risk for Parkinson’s Disease Age at Onset in European Sub-Populations: from the Global Parkinson’s Genetics Program
-
Assessing Individual Risk Through Determination of Local Ancestry: Insights from the Global Parkinson’s Genetics Program
-
Assessing Physiotherapy’s Role in Parkinson’s Disease Functionality in India: A Case Report
-
Assessing the Impact of Interprofessional Education on Collaborative Practice in Neurorehabilitation for Parkinson’s Disease: A Systematic Review
-
Assessing the potential association of rs2298383 in ADORA2A as a predictor of Levodopa-Induced Dyskinesia in Latin American Parkinson’s Disease patients
-
Assessing the Relationship Between Autonomic Symptom Burden and Autonomic Failure in Parkinson’s Disease
-
Assessment of cognitive impairment in Parkinson’s disease in Bangladeshi patients in Dhaka as part of the London-Dhaka Parkinson’s Cognition Study
-
Assessment of Hypomimia in Parkinson’s Disease
-
Assessment of mitochondrial DNA copy number and common deletion (del4977) as candidate peripheral biomarkers for Spinocerebellar ataxia type 2
- « Previous Page
- 1
- …
- 17
- 18
- 19
- 20
- 21
- …
- 181
- Next Page »